Covered recipient · General Payments record
STEFFEN SHAMBURG
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$2,662.02
- Reported across 169 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $261.42 | 14 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $65.85 | 3 |
| ABBVIE INC. | $49.65 | 2 |
| Novo Nordisk AS | $32.40 | 2 |
| Amgen Inc. | $28.63 | 2 |
| Janssen Pharmaceuticals, Inc | $21.53 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $16.67 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $15.80 | 1 |
| Antares Pharma, Inc. | $15.72 | 1 |
| Abbott Laboratories | $15.17 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $15.17 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125169506 | CMS |
| ABBVIE INC. | $24.31 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106071190 | CMS |
| ABBVIE INC. | $25.34 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106071192 | CMS |
| Amgen Inc. | $14.95 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117681240 | CMS |
| Amgen Inc. | $13.68 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116110299 | CMS |
| Antares Pharma, Inc. | $15.72 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146484991 | CMS |
| Janssen Pharmaceuticals, Inc | $21.53 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078022546 | CMS |
| Lilly USA, LLC | $23.44 | 01/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135411665 | CMS |
| Lilly USA, LLC | $24.32 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135349794 | CMS |
| Lilly USA, LLC | $18.09 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135349796 | CMS |
| Novo Nordisk Inc | $14.83 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096689927 | CMS |
| Novo Nordisk Inc | $17.57 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097179449 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $15.80 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153644951 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $16.67 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137673445 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.